These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 134480

  • 1. [Study of the fibrinogen splitting products in the blood plasma in hyperfibrinolysis].
    Veremienko KN, Varetskaia TV, Kizim AI, Gerasimenko NG.
    Ukr Biokhim Zh; 1976; 48(3):337-42. PubMed ID: 134480
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
    Chek JB, Panchenko NI.
    East Afr Med J; 2000 Apr; 77(4):217-20. PubMed ID: 12858907
    [Abstract] [Full Text] [Related]

  • 3. [Antiplasmin and its effect on the process of fibrinolysis in experiments].
    Kudriashov BA, Pastorova VE.
    Biull Eksp Biol Med; 1966 Feb; 61(2):40-2. PubMed ID: 4235805
    [No Abstract] [Full Text] [Related]

  • 4. Studies on the participation of Hageman factor in fibrinolysis.
    McDonagh RP, Ferguson JH.
    Thromb Diath Haemorrh; 1970 Oct 31; 24(1):1-9. PubMed ID: 4249468
    [No Abstract] [Full Text] [Related]

  • 5. The thrombolytic activity of streptokinase in the rabbit.
    English PD, Smith RA, Dupe RJ, Green J, Hibbs MJ.
    Thromb Haemost; 1981 Aug 28; 46(2):535-7. PubMed ID: 7302893
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differential inhibition with antifibrinolytic agents of staphylokinase and streptokinase induced clot lysis.
    Lijnen HR, Stassen JM, Collen D.
    Thromb Haemost; 1995 May 28; 73(5):845-9. PubMed ID: 7482414
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study.
    Geratz JD.
    Thromb Diath Haemorrh; 1971 Jun 30; 25(3):391-404. PubMed ID: 5314899
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Animal experimental studies on fibrinolysis with streptokinase].
    Hauptmann J, Klöcking HP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979 Jun 30; 106(5-6):915-22. PubMed ID: 94886
    [Abstract] [Full Text] [Related]

  • 12. Preferential degradation of soluble fibrin monomers in streptokinase-activated plasma.
    Konttinen YP, Lalla ML, Turunen O.
    Thromb Diath Haemorrh; 1973 Nov 30; 30(2):403-13. PubMed ID: 4543990
    [No Abstract] [Full Text] [Related]

  • 13. [Proof of the antifibrinolytic action of the protease inhibitor Contrykal in vivo].
    Klöcking HP.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1967 Nov 30; 88(2):136-41. PubMed ID: 4174651
    [No Abstract] [Full Text] [Related]

  • 14. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H.
    Thromb Diath Haemorrh; 1973 May 10; 29(2):253-75. PubMed ID: 4271586
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fibrin deposition in the ribbit kidney produced by protease inhibitors.
    Beller FK, Mitchell PS, Gorstein F.
    Thromb Diath Haemorrh; 1967 May 31; 17(3-4):427-39. PubMed ID: 5301528
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.